|  | Unadjusted |  | Adjusteda |  |
---|---|---|---|---|---|
 | TJA group | OR (95% CI) | P-value | OR (95% CI) | P-value |
Antiepileptic | Â | Â | Â | Â | Â |
31–90 Days | Knee | 1.74 (1.29, 2.35) |  < 0.001 | 1.74 (1.26, 2.40) |  < 0.001 |
Shoulder | 2.37 (1.56, 3.59) |  < 0.001 | 2.42 (1.58, 3.72) |  < 0.001 | |
Hip | REF | REF | REF | REF | |
0–365 Days | Knee | 1.49 (1.21, 1.83) |  < 0.001 | 1.44 (1.16, 1.80) | 0.001 |
Shoulder | 1.41 (1.02, 1.95) | 0.035 | 1.45 (1.04, 2.03) | 0.028 | |
Hip | REF | REF | REF | REF | |
Antibiotics | Â | Â | Â | Â | Â |
31–90 Days | Knee | 1.20 (0.95, 1.51) | 0.129 | 1.24 (0.97, 1.57) | 0.088 |
Shoulder | 1.05 (0.72, 1.51) | 0.813 | 0.97 (0.67, 1.41) | 0.867 | |
Hip | REF | REF | REF | REF | |
0–365 Days | Knee | 1.28 (1.02, 1.59) | 0.032 | 1.29 (1.02, 1.63) | 0.032 |
Shoulder | 1.03 (0.73, 1.46) | 0.852 | 0.95 (0.67, 1.35) | 0.765 | |
Hip | REF | REF | REF | REF | |
NSAIDS | Â | Â | Â | Â | Â |
31–90 Days | Knee | 1.35 (1.02, 1.80) | 0.039 | 1.39 (1.03, 1.89) | 0.032 |
Shoulder | 1.48 (0.97, 2.27) | 0.068 | 1.70 (1.10, 2.64) | 0.018 | |
Hip | REF | REF | REF | REF | |
0–365 Days | Knee | 1.12 (0.91, 1.37) | 0.287 | 1.07 (0.86, 1.33) | 0.531 |
Shoulder | 0.90 (0.65, 1.24) | 0.501 | 0.98 (0.70, 1.37) | 0.911 | |
Hip | REF | REF | REF | REF | |
Opioids | Â | Â | Â | Â | Â |
31–90 days | Knee | 1.54 (1.22, 1.96) |  < 0.001 | 1.68 (1.30, 2.18) |  < 0.001 |
Shoulder | 1.20 (0.83, 1.75) | 0.331 | 1.26 (0.85, 1.86) | 0.255 | |
Hip | REF | REF | REF | REF | |
0–365 days | Knee | 1.48 (1.16, 1.89) | 0.002 | 1.44 (1.11, 1.87) | 0.005 |
Shoulder | 1.30 (0.88, 1.92) | 0.188 | 1.36 (0.91, 2.02) | 0.135 | |
Hip | REF | REF | REF | REF |